Telemedicine-supported insulin optimisation in primary care.
We investigated the feasibility of a mobile-phone based system for patients with type 2 diabetes who had recently commenced insulin therapy but remained poorly controlled. The system was evaluated in a feasibility study in a general practice setting with 23 patients over six months. A total of 22 pa...
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2010
|
| _version_ | 1797079980380782592 |
|---|---|
| author | Larsen, M Turner, J Farmer, A Neil, A Tarassenko, L |
| author_facet | Larsen, M Turner, J Farmer, A Neil, A Tarassenko, L |
| author_sort | Larsen, M |
| collection | OXFORD |
| description | We investigated the feasibility of a mobile-phone based system for patients with type 2 diabetes who had recently commenced insulin therapy but remained poorly controlled. The system was evaluated in a feasibility study in a general practice setting with 23 patients over six months. A total of 22 patients successfully completed the study and used the system for a mean of 217 days (range 162-376). Blood glucose control improved, as reflected by a mean decrease in HbA(1c) of 0.66% (P = 0.05), with the mean insulin dose increasing by 17 units (P = 0.006). Blood glucose monitoring compliance was high, with readings available for 6.2 days per week, although use of the mobile phone decreased during the study. On average, the mobile phone diary was used for 3.5 days per week. Insulin dose adjustments were made throughout the study by all patients, but not as frequently as would be expected for the degree of hyperglycaemia observed. |
| first_indexed | 2024-03-07T00:53:40Z |
| format | Journal article |
| id | oxford-uuid:8742b702-b37c-4f39-861b-3ef706c05f27 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T00:53:40Z |
| publishDate | 2010 |
| record_format | dspace |
| spelling | oxford-uuid:8742b702-b37c-4f39-861b-3ef706c05f272022-03-26T22:09:34ZTelemedicine-supported insulin optimisation in primary care.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8742b702-b37c-4f39-861b-3ef706c05f27EnglishSymplectic Elements at Oxford2010Larsen, MTurner, JFarmer, ANeil, ATarassenko, LWe investigated the feasibility of a mobile-phone based system for patients with type 2 diabetes who had recently commenced insulin therapy but remained poorly controlled. The system was evaluated in a feasibility study in a general practice setting with 23 patients over six months. A total of 22 patients successfully completed the study and used the system for a mean of 217 days (range 162-376). Blood glucose control improved, as reflected by a mean decrease in HbA(1c) of 0.66% (P = 0.05), with the mean insulin dose increasing by 17 units (P = 0.006). Blood glucose monitoring compliance was high, with readings available for 6.2 days per week, although use of the mobile phone decreased during the study. On average, the mobile phone diary was used for 3.5 days per week. Insulin dose adjustments were made throughout the study by all patients, but not as frequently as would be expected for the degree of hyperglycaemia observed. |
| spellingShingle | Larsen, M Turner, J Farmer, A Neil, A Tarassenko, L Telemedicine-supported insulin optimisation in primary care. |
| title | Telemedicine-supported insulin optimisation in primary care. |
| title_full | Telemedicine-supported insulin optimisation in primary care. |
| title_fullStr | Telemedicine-supported insulin optimisation in primary care. |
| title_full_unstemmed | Telemedicine-supported insulin optimisation in primary care. |
| title_short | Telemedicine-supported insulin optimisation in primary care. |
| title_sort | telemedicine supported insulin optimisation in primary care |
| work_keys_str_mv | AT larsenm telemedicinesupportedinsulinoptimisationinprimarycare AT turnerj telemedicinesupportedinsulinoptimisationinprimarycare AT farmera telemedicinesupportedinsulinoptimisationinprimarycare AT neila telemedicinesupportedinsulinoptimisationinprimarycare AT tarassenkol telemedicinesupportedinsulinoptimisationinprimarycare |